Chinese herb trial for brain bleed linked to amyloid angiopathy
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain bleed in the upper part of your brain that is 40 milliliters or less.
- You started having symptoms within the last 7 days.
- Your doctor thinks it might be caused by a condition called cerebral amyloid angiopathy (protein buildup in brain blood vessels).
- You are between 50 and 90 years old.
- You are alert enough to give consent (GCS score of 8 or higher).
- You have mild to moderate stroke symptoms (NIHSS score 25 or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
This trial tests an experimental medicine called ALN-APP for people with a condition called cerebral amyloid angiopathy (CAA) — a buildup of protein in brain blood vessels that can cause bleeding. The drug aims to reduce this protein and possibly prevent future strokes.
This study tests whether the drug LXB (sodium oxybate) can help clear abnormal protein buildup in the brain's small blood vessels (CAA). Participants will take LXB nightly for 8 weeks and have MRIs and spinal taps to measure changes.
This trial tests whether a Chinese herbal pill called naoxuekang can help people recover from a bleeding stroke caused by high blood pressure. It is for people who have had a small to moderate bleed within the last week and are in stable condition.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
Hear when a new Cerebral Amyloid Angiopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.